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Abstract
Background: We analyzed the causal relationship between LDL susceptibility to oxidation and the development of
new carotid artery atherosclerosis over a period of 5 years. We previously described the determinants related to a
risk of cardiovascular changes determined in a Japanese population participating in the Niigata Study, which is an
ongoing epidemiological investigation of the prevention of cardiovascular diseases.
Methods: We selected 394 individuals (169 males and 225 females) who underwent a second carotid artery
ultrasonographic examination in 2001 - 2002 for the present study. The susceptibility of LDL to oxidation was
determined as the photometric absorbance and electrophoretic mobility of samples that had been collected in
1996 - 1997. The measurements were compared with ultrasonographic findings obtained in 2001 - 2002.
Results: The multivariate-adjusted model showed that age (odds ratio (OR), 1.034; 95% confidence interval (95%CI),
1.010 - 1.059), HbA1c (OR, 1.477; 95%CI, 0.980 - 2.225), and photometric O/N (OR, 2.012; 95%CI, 1.000 - 4.051) were
significant variables that could independently predict the risk of new carotid artery atherosclerosis.
Conclusion: The susceptibility of LDL to oxidation was a significant parameter that could predict new carotid
artery atherosclerosis over a 5-year period, and higher susceptibility was associated with a higher incidence of new
carotid artery atherosclerosis.
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Background
The oxidation of low-density lipoprotein (LDL) is widely
believed to be an important event in the pathogenesis of
atherosclerosis. Macrophages endocytose oxidized LDL
in an uncontrolled manner, which results in the genera-
tion of cholesterol-laden foam cells that characterize
atherosclerotic lesions [1,2]. The oxidation of LDL in
vitro can be mediated by cells or mimicked in a cell free
system using transition metal ions such as copper or
iron as prooxidants [3,4]. Metal ions are usually prere-
quisite for LDL oxidation, at least in vitro. Catalytically
active copper and iron are also present in human ather-
osclerotic lesions [5].
The initial step of LDL oxidation is the peroxidation
of polyunsaturated fatty acids among LDL lipids. Frag-
ments of modified fatty acids covalently attach to
apolipoprotein B-100 (apoB-100) and neutralize its posi-
tively charged epsilon-amino acid group [2,6]. Another
possible mechanism of the oxidation is that copper
directly binds to apoB-100 at sites that are located at
least on regions containing histidine [4]. Dietary antioxi-
dants such as flavonoids and Vitamin E might help to
inhibit copper binding to LDL [7,8].
One way of detecting oxidized LDL is to compare its
photometric absorbance at 232 nm with that of native
LDL [9]. An increase in photometric absorbance at 232
nm is due to the formation of conjugated dienes of fatty
acid hydroperoxides. Continuous monitoring of the
photometric absorbance of LDL under artificial modifi-
cation shows a lag phase of which the rate is related to
the antioxidant content and/or alterations in the surface
structure [10-12]. This lag time is an independent para-
meter that can be used to evaluate the dynamics of LDL
oxidation. Another popular method for detecting the
process of oxidation is to measure the amount of thio-
barbituric acid reactive substances (TBARS) that
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dized LDL [13]. Electrophoretic mobility is also a con-
ventional parameter that reflects an altered surface
charge [14]. The susceptibility of LDL to oxidation is
usually evaluated using the lag time, but this method is
ad hoc and not standardized. Photometric absorbance
and electrophoretic mobility are robust parameters that
linearly correlate with the extent of LDL oxidation [15].
The role of LDL susceptibility in predicting new cardi-
ovascular events is not yet fully elucidated. The present
study analyzes the causal relationship between LDL sus-
ceptibility to oxidation and the development of new car-
otid artery atherosclerosis in a cohort that we have
prospectively followed up for 5 years.
Materials and methods
We previously described the determinants that are
related to the risk of cardiovascular changes in a Japa-
nese population that is participating in the ongoing epi-
demiological Niigata Study of the prevention of
cardiovascular disease [16]. Full details of the study have
been reported [17]. Briefly, 2164 individuals (1011 men
and 1153 women; 23 - 89 years of age) were recruited
from a single Japanese community in 1996 - 1997. The
exclusion criteria at the initial entry comprised current
and previous medication, history of diabetes mellitus,
history of cardiovascular disease and fasting plasma glu-
cose (FPG) > 0.69 mmol/L (125 mg/dL). All data were
collected, analyzed and evaluated at a local health cen-
ter. Plasma samples derived from venous blood anticoa-
gulated with 3.4 mmol/L ethylenediamine tetra acetate
(K2EDTA), were collected from all participants and
immediately stored at -70°C.
The present study selected 394 individuals (169 males
and 225 females) from the study cohort who underwent
a second carotid artery ultrasonographic evaluation in
2001 - 2002 and met the criterion described below. The
susceptibility of LDL to oxidation in the samples that
had been stored since 1996 - 1997 was determined as
photometric absorbance and electrophoretic mobility
and the results were compared with the ultrasono-
graphic findings obtained in 2001 - 2002. The Commit-
tee on Human Research, Niigata University School of
Medicine, Japan approved the study protocol, and all
participants provided written informed consent.
We prepared LDL (1.019 - 1.063 g/ml) using ultracen-
trifugation as follows. Sodium bromide (1.0 mL; 1.025 g/
mL) containing 0.01% (w/w) NaN3, 0.3 mmol/L
Na2EDTA, and 1 mmol/L benzamide hydrochloride was
gently added to 2 mL of plasma, and the mixture was
separated by ultracentrifugation at 400,000 × g (at the
bottom of tube) at 4°C for 5 h using a Himac centrifuge
CS100 (Hitachi Koki, Tokyo, Japan) and an S100AT5
rotor. The bottom fraction (2.0 mL) was then transferred
to another tube and the density was increase to 1.063
using NaBr (1.151 g/mL). After repeated centrifugation
at 400,000 × g at 4°C for 5 h, the top fraction was dec-
anted and the container was filled with nitrogen and
stored in the dark at 4°C until analysis. The LDL fractions
were protected from the sun and room light, which can
cause oxidation, and analyzed within 24 h of preparation.
Before oxidation, each LDL fraction was passed
through a Sephadex G-25 column (PD-10™,P h a r m a c i a
Biotech, Uppsala, Sweden) to change the buffer to phos-
phate-buffered saline (PBS). The protein content of LDL
samples was determined using a protein assay kit (Bio-
Rad Laboratories, Inc., Tokyo, Japan) based on the Brad-
ford method with bovine serum albumin as a standard,
and adjusted to 100 μg/mL (final concentration). Copper
sulfate (final concentration, 4 μmol/L) was added to
each sample, incubated for 5 h, and then oxidation was
stopped by separating the copper ions from LDL pas-
sage through a PD-10 column.
Trypsin (200 μg/ml) was added to native LDL (final
protein concentration, 100 μg/ml) and incubated for 2 h
at 37°C. Proteins that were non-specifically attached to
LDL particles in portions of digested LDL were immedi-
ately resolved by 4 - 12% gradient polyacrylamide gel
electrophoresis with sodium dodecyl sulfate (SDS-
PAGE). The separated proteins were transferred to a
polyvinylidene difluoride membrane (ATTO, Tokyo,
Japan) and then bands were visualized by staining with
Coomassie Brilliant Blue and sequenced at a separate
facility (Takara Bio Inc., Otsu, Japan).
The susceptibility of LDL to oxidation was photome-
trically assessed using a DU 600 spectrophotometer
(Beckman Instruments, Fullerton, CA, USA). Pairs of
native and oxidized LDL samples were diluted with PBS
to a protein concentration of 20 μg/mL and then absor-
bance was measured at 232 nm [14]. The ratio of the
absorbance of oxidized LDL to that of native LDL
(photometric O/N) was defined as a parameter of LDL
susceptibility to oxidation.
We evaluated changes in surface charge as the electro-
phoretic mobility of native and oxidized LDL separated
on 1.0% agarose gel films (TITAN GEL Lipoprotein,
Helena Laboratories, Saitama, Japan) in 0.08 mol/L bar-
bital buffer (pH 8.6), 90 V for 25 min according to the
manufacturer’s instructions. Lipoproteins were visualized
by staining with 0.04 (w/v) Fat Red 7B in 95% methanol.
The amount of protein in each applied sample was
adjusted to a final concentration of 100 μg/mL. The
relative mobility of LDL bands was automatically mea-
sured as distance in millimeters using an AE-6981GXCP
ATTO COMBO II imager (ATTO, Tokyo, Japan). We
defined the ratio of the distance migrated by oxidized to
native LDL (electrophoretic O/N) as another parameter
of LDL susceptibility to oxidation.
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medial thickness (IMT) measured by high-resolution B-
mode ultrasonography according to Salonen et al. [18]
using a TOSBEE scanner (Toshiba, Tokyo, Japan)
equipped with a 7.5-MHz sector scanner probe (model
PLF-705S; Toshiba) and a digital scan converter. The
extracranial carotid arteries of supine participants were
scanned from the lowest portion visible in the supracla-
vicular fossa to the carotid bifurcation. Determinations
of IMT were based on the most severely affected site in
either the right or left side of the neck. Affected sites
included homogeneous thickening and localized plaque
with or without calcification or ulceration or both. We
did not classify the findings because homogeneous
thickening and localized plaque can be difficult to discri-
minate. A trained sonographer performed all IMT mea-
surements using image-morphometry software and an
experienced physician validated all findings to eliminate
concerns about inter-reader variability and erroneous
reading.
In 1996 - 1997, blood collected after an overnight fast
from an antecubital vein from seated subjects was tested
within 3 h. The plasma insulin concentration was deter-
mined using an enzyme immunoassay (AxSYM Insulin,
Dainabot, Tokyo, Japan) and FPG was measured using a
glucose oxidase-oxygen electrode and Glucoreader-C
(Shino-Test, Tokyo, Japan). Hemoglobin type A1c
(HbA1c) was measured using high-performance liquid
chromatography on an HLC-723GHb column (Tosoh,
Tokyo, Japan). Serum total cholesterol (TC,) triglyceride
(TG), and high density lipoprotein cholesterol (HDL-C)
were enzymatically measured using a model 736 auto-
matic analyzer (Hitachi, Tokyo, Japan). The amount of
LDL cholesterol (LDL-C) was calculated from the
amounts of TC, HDL-C, and TG using Friedewald’s
formula.
Seated systolic (SBP) and diastolic (DBP) blood pres-
sure were measured at the upper arm using a sphygmo-
manometer. Subjects refrained from physical activity,
eating and smoking for at least 30 min before measure-
ment. We recorded SBP as the appearance of Korotkoff
sounds, and DBP as their disappearance. Body mass
index (BMI), calculated as weight (kg) divided by the
square of height (m) [kg/m
2] served as an index of over-
all adiposity.
The primary event was defined as IMT ≥ 0.8 mm in
2001- 2002 and IMT ≤ 0.7 mm in 1996 - 1997. Univari-
ate analyses were performed using Student’s t test and
the Mann-Whitney test. The odds ratio (OR) of LDL
susceptibility to oxidation to predict the risk of new car-
otid artery atherosclerosis was estimated by logistic
regression modeling. Individuals with positive events in
2001 - 2002 were assigned 1 as the dependent variable
in the logistic regression analysis; otherwise, 0 was
assigned. To analyze the effect of potential confounders
on the OR, we firstly adjusted the multivariate models
for age only and then by including sex, LDL-C, HDL-C,
TG, FPG, HbA1c, fasting insulin, SBP, DBP, BMI,
photometric O/N, and electrophoretic O/N. A signifi-
cant subset of independent risk factors was selected by
backward stepwise elimination. All data were statistically
analyzed using SPSS software, version 11.0J for Win-
dows (SPSS Japan Inc). Values are expressed as means ±
standard deviation (± SD). We calculated the 95% confi-
dence interval (CI) for all ORs.
Results
Electrophoretic SDS-PAGE separation of trypsinized
LDL revealed over 10 bands, among which, macroglobu-
lin a2, albumin, fibrinogen b chain precursor and hapto-
globin precursor predominated (Figure. 1). Since the
electrophoretic profile was identical in ten randomly
selected samples, we concluded that these proteins non-
specifically attach to apoB-100. The photometric and
electrophoretic O/Ns for both native and trypsinized
LDL did not significanty differ.
Individual samples were repeatedly measured by both
photometry (n = 20) and electrophoresis (n = 24). The
intra-assay imprecision (coefficient of variation; CV) was
5.7% and 1.35%, respectively, and electrophoresis was
more reproducible than photometry.
We used photometry and electrophoresis to determine
the effects of temperature in two portions of the same
sample stored at -70°C and +4°C for 14 days. Differ-
ences between values for each pair of aliquots were
within the limits of intra-assay imprecision.
Table 1 shows the 1996 - 1997 characteristics of the
participants with and without new carotid artery athero-
sclerosis that developed during the 5-year follow-up.
Participants with carotid artery atherosclerosis were
older and had higher levels of FPG and HbA1c. No
other variables were significantly associated.
Table 2 provides two logistic regression models for
predicting the risk of carotid artery atherosclerosis inci-
dents with 13 variables including both O/Ns. There was
no significant variable in the age-adjusted model and
also in the multivariate-adjusted model except age. Ana-
lysis by backward stepwise elimination, in which the cri-
terion for determining variables to be removed from the
model was the likelihood ratio, showed that age (OR,
1.034; 95%CI, 1.010 - 1.059); HbA1c (OR, 1.477; 95%CI,
0.980 - 2.225); and photometric O/N (OR, 2.012; 95%CI,
1.000 - 4.051) were significant variables that could inde-
pendently predict the risk of carotid artery atherosclero-
sis (Table 3).
Figure 2 shows two receiver operating characteristic
curves (ROC) representing the sensitivity and specificity
of photometric O/N. The area under the curve (AUC)
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metric O/N = 1.8, 1.9 and 2.0, the sensitivity and speci-
ficity were 0.719 and 0.415, 0.536 and 0.548 and 0.373
and 0.647, respectively.
Discussion
The present study found that LDL susceptibility to oxi-
dation in combination with age and HbA1c was a signif-
icant parameter that predicted new carotid artery
atherosclerosis over a period of 5 years. Higher
susceptibility was associated with a higher incidence of
carotid artery atherosclerosis.
The oxidative process initiated after copper ions are
added to LDL particles is extremely complex [10,14,19].
Lipid peroxidation starts within 30 min, peaks at 2 h,
and then the amount of products decreases. Modifica-
tions are accelerated after 60 min, but apoB-100 is quite
difficult to modify. Phospholipids initially undergo a
structural change and then conjugated diene breakdown
products accelerate modification. ApoB-100 thus modi-
fied or its fragments accelerate further phospholipid
modification. Although the direct binding of copper
ions to apolipoproteins before these oxidative processes
begin is accepted as fact, it cannot be observed by exist-
ing methods. Because conjugated diene formation
empirically peaks within 2 - 5 h [14,20,21], we executed
the measurements after a 5-h incubation. The photo-
metric values of frozen and fresh LDL samples did not
significantly differ, indicating that the integrity of the
LDL samples used in the present study was preserved
during storage.
The differing susceptibility of LDL to oxidation among
individuals can be explained as follows. One is that LDL
consists of a continuum of particles that can be classi-
fied according to their physical and chemical properties
such as particle size, buoyant density, chemical composi-
tion, surface electrical charge and hydrodynamic beha-
viour [22]. Many studies have demonstrated that small
dense LDL particles are easily oxidized and closely cor-
relate with future atherosclerotic events. For example,
Holvoet et al. reported that adding a parameter such as
circulating oxidized LDL to the established risk factors
Figure 1 SDS-PAGE of trypsinized LDL samples.M a c r o g l o b u l i na2, albumin, fibrinogen b chain precursor and haptoglobin precursor
comprised four major bands identified by sequencing. Neither photometric nor electrophoretic O/N significantly differed between native and
trypsinized LDLs.
Table 1 Baseline characteristics of 394 participants in
1996 - 1997
Characteristic IMT in 2001-2002 P
≤ 0.7 mm ≥ 0.8 mm
n 241 153
Age 54.8 57.9 0.001
Sex (male/female) (n) 98/143 71/82 0.262
LDL cholesterol (mmol/L) 2.92 (0.76)
a 3.07 (0.73) 0.068
HDL cholesterol (mmol/L) 1.46 (0.37) 1.46 (0.44) 0.975
Triglyceride (mmol/L) 1.11 (0.71) 1.20 (0.69) 0.223
Fasting plasma glucose (mmol/L) 5.27 (0.66) 5.44 (0.92) 0.035
HbA1c (%) 5.01 (0.6) 5.16 (0.6) 0.012
Fasting insulin (pmol/L) 29.4 (17) 31.1 (32) 0.492
Systolic blood pressure (mmHg) 125 (19) 126 (19) 0.401
Diastolic blood pressure (mmHg) 77 (10) 77 (9) 0.512
Body mass index (kg/m
2) 22.6 (2.7) 22.9 (2.7) 0.298
Photometric O/N 1.90 (0.31) 1.95 (0.29) 0.156
Electrophoretic O/N 2.38 (0.29) 2.37 (0.25) 0.597
aMean (standard deviation).
Aoki et al. Lipids in Health and Disease 2012, 11:4
http://www.lipidworld.com/content/11/1/4
Page 4 of 7might improve cardiovascular risk prediction [23]. Lie et
al. reported that circulating oxidized LDL significantly
correlates with LDL particle size in families with familial
combined hyperlipidemia [24]. However, a study of dia-
betic patients found that plasma levels of oxidized LDL
correlate only with the duration of diabetes indepen-
dently of LDL size [25]. Kiechl et al. demonstrated that
plasma levels of oxidized phospholipids on Lp(a) parti-
cles measured at baseline in an unselected population
derived from the general community predicted the
development of cardiovascular events over a 10-year
prospective follow-up period [26]. Plasma LDL suscept-
ibility to oxidation depends not only on the structural
features of LDL but also on lifestyle characteristics such
as daily consumption of fruits, vegetables, supplements
or drugs [27-30]. The mechanism and atherogenesis of
LDL oxidation are still not completely understood, and
the theory of oxidized LDL remains controversial.
A crucial issue could be copper binding sites that
become easily saturated not only by copper but also by
antioxidants. Epidemiological studies suggest that a high
intake of dietary antioxidants such as vitamin C, vitamin
E, b-carotene is associated with a reduced risk of cardio-
vascular disease [7,8]. The non-radical decomposition of
hydroperoxide (LOOH) can also modify the progress of
peroxidation [31,32]. This indicates that individuals have
some LDL that has already undergone an oxidative
modification, which might increase the susceptibility of
LDL to oxidation. Lankin et al. described the interesting
findings that therapy with a 3-hydroxy-3-methylglutaryl-
coenzyme A-reductase inhibitor (simvastatin) is asso-
ciated with the intense accumulation of peroxidation
products on the LDL of patients with coronary heart
disease, despite having a decreased cholesterol level [33].
T h ep r e s e n ts t u d yh a st h ef ollowing limitations. We
defined cardiovascular events based on ultrasonographic
measurements of the carotid artery and we did not
include definitive variables such as angiographic find-
ings. The participants in the Niigata study were initially
healthy men and women without a history of cardiovas-
cular diseases. Carotid artery ultrasonography is widely
recognized as a valid non-invasive surrogate for detect-
ing atherosclerosis, and several variables have already
been directly implicated in increasing IMT [34]. Given
this information, ultrasonography was the logical choice
for the present study. The samples that we analyzed
were frozen once and stored at -70°C for years.
Although the experimental values did not significantly
differ between fresh samples and those stored for 2
weeks at -70°C, the influence of temperature should be
further clarified in the future.
In conclusion, we found that high susceptibility of
LDL to oxidation was a significant parameter for
Table 2 Multivariable odds ratios of risk factors at baseline for future increase in IMT
Characteristic
a Age-adjusted model
b Multivariate model
c
OR (95% CI)
d P OR (95% CI) P
Age 1.035 (1.009 - 1.062) 0.009
Sex (male/female) (n) 0.744 (0.491 - 1.129) 0.165 0.732 (0.454 - 1.179) 0.199
LDL cholesterol (mmol/L) 1.005 (0.998 - 1.012) 0.147 1.006 (0.998 - 1.014) 0.144
HDL cholesterol (mmol/L) 1.000 (0.987 - 1.013) 0.998 1.010 (0.994 - 1.026) 0.234
Triglyceride (mmol/L) 1.002 (0.998 - 1.005) 0.371 1.001 (0.997 - 1.005) 0.670
Fasting plasma glucose (mmol/L) 1.012 (0.996 - 1.027) 0.137 1.001 (0.983 - 1.021) 0.877
HbA1c (%) 1.440 (0.960 - 2.160) 0.078 1.421 (0.878 - 2.298) 0.153
Fasting insulin (pmol/L) 1.017 (0.996 - 1.070) 0.531 1.013 (0.958 - 1.071) 0.646
Systolic blood pressure (mmHg) 1.000 (0.989 - 1.011) 0.985 0.995 (0.979 - 1.012) 0.589
Diastolic blood pressure (mmHg) 1.006 (0.985 - 1.027) 0.596 1.009 (0.978 - 1.041) 0.574
Body mass index (kg/m
2) 1.035 (0.959 - 1.119) 0.376 1.026 (0.937 - 1.123) 0.584
Photometric O/N 1.919 (0.959 - 3.838) 0.065 1.943 (0.931 - 4.056) 0.077
Electrophoretic O/N 1.031 (0.479 - 2.220) 0.937 0.908 (0.386 - 2.135) 0.825
aData at 1996-1997.
bData adjusted for age.
cVariables in model were age, sex, LDL-cholesterol, HDL-cholesterol, triglyceride, fasting plasma glucose, HbA1c,
fasting insulin, systolic blood pressure, diastolic blood pressure, BMI, photometric O/N, and electrophoretic O/N.
dOR, odds ratio; CI, 95% confidence interval.
Table 3 Odds ratios of variables selected by backward
stepwise elimination
Characteristic
a Multivariate OR (95% CI)
b,c P
Age 1.034 (1.010 - 1.059) 0.005
HbA1c (%) 1.477 (0.980 - 2.225) 0.062
Photometric O/N 2.012 (1.000 - 4.051) 0.050
aData in 1996-1997;
bOR, odds ratio; CI, confidence interval;
cVariables
evaluated for elimination were age, sex, LDL-cholesterol, HDL-cholesterol,
triglyceride, fasting plasma glucose, HbA1c, fasting insulin, systolic blood
pressure, diastolic blood pressure, BMI, and photometric O/N, and
electrophoretic O/N.
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atherosclerosis.
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